<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>chemotherapy resistance prediction &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/chemotherapy-resistance-prediction/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 10:13:06 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>chemotherapy resistance prediction &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>New Test Developed to Predict Patient Resistance to Cancer Chemotherapy</title>
		<link>https://bioengineer.org/new-test-developed-to-predict-patient-resistance-to-cancer-chemotherapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 23 Jun 2025 09:27:35 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[chemotherapy resistance prediction]]></category>
		<category><![CDATA[chromosomal instability biomarkers]]></category>
		<category><![CDATA[computational oncology models]]></category>
		<category><![CDATA[genomic testing in cancer]]></category>
		<category><![CDATA[precision oncology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-test-developed-to-predict-patient-resistance-to-cancer-chemotherapy/</guid>

					<description><![CDATA[In a groundbreaking advancement poised to revolutionize oncological treatment, scientists at the Spanish National Cancer Research Centre (CNIO) have unveiled a novel genomic test capable of predicting which cancer patients are unlikely to respond to conventional chemotherapy. This innovation not only promises to spare patients the debilitating side effects of ineffective treatments but also ushers [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">250117</post-id>	</item>
	</channel>
</rss>
